Gyeonggi-do, South Korea

Dong-Keun Song

This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Il Dong Pharmaceutical Co., Ltd., Ildong Pharm Co., Ltd., Biosynergen, Inc.. Active years: 2008-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong-Keun Song. Retrieved from https://idiyas.com/inventor/dong-keun-song

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 8.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Kangwon-do, KR (2008)
  • Gyeonggi-do, KR (2017 - 2022)
  • Seoul, KR (2021 - 2024)
  • Hwaseong-si, KR (2023 - 2024)

Company Filing History:


Years Active: 2008-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dong-Keun Song

Introduction

Dong-Keun Song is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of eight patents. His work focuses on developing compounds that have the potential to address various medical conditions.

Latest Patents

Among his latest patents, Dong-Keun Song has developed autotaxin inhibitor compounds. This patent provides compositions that include autotaxin (ATX) inhibitor compounds, along with methods for using these compounds to inhibit ATX. Additionally, he has created isoxazole derivatives that serve as nuclear receptor agonists. This invention offers methods for treating metabolic diseases, cholestatic liver diseases, or organ fibrosis through the administration of a therapeutically effective amount of a pharmaceutical composition containing isoxazole derivatives.

Career Highlights

Dong-Keun Song has worked with notable companies in the pharmaceutical industry, including Il Dong Pharmaceutical Co., Ltd. and Ildong Pharm Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Dong-Keun Song has collaborated with esteemed colleagues such as Yoon-Suk Lee and Kyung-Sun Kim. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Dong-Keun Song's innovative work in developing pharmaceutical compounds demonstrates his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…